Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis

The off-label use of bevacizumab labeled with 99mTc as a new radiopharmaceutical for imaging of endometriosis is a promising noninvasive, new clinical procedure. The bevacizumab in monoclonal antibodies targeted at vascular endothelial growth factor (VEGF) is superexpressed in cases of endometriosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Daniel Escorsim, Perini, Jamila Alessandra, Orlando, Margarida Maria Camoes, Santos-Oliveira, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512512/
https://www.ncbi.nlm.nih.gov/pubmed/26240826
http://dx.doi.org/10.1155/2015/751460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512512/
https://www.ncbi.nlm.nih.gov/pubmed/26240826
http://dx.doi.org/10.1155/2015/751460

Ejemplares similares